Novo Nordisk shares dropped due to CagriSema trial results but have long-term upside. Learn why NVO stock is a Strong Buy ...

Traders were on guard after Federal Reserve Chair Jerome Powell said on Tuesday that the central bank is in no hurry to lower ...

Big pharma’s pushing for PBS funding, and it’s kickstarting a shift to healthier snacks, smaller portions, and more ...

That’s why one of the most closely watched elements of a company’s earnings report is the guidance it gives for the next quarter or year. We’re still midway through the current earnings season, but ...

Some of the market’s biggest winners start off as the smallest players. While trillion-dollar tech giants like the ...

Viking Therapeutics (NASDAQ: VKTX) shares exploded higher after the clinical-stage drugmaker announced successful results ...

Online dating apps have struggled amid lulls in growth and user frustration with the services. Amid a change in leadership at ...

Tapestry, which owns Coach, Kate Spade and Stuart Weitzman brands, reported second-quarter revenue of $2.2 billion, beating analyst estimates of $2.11 billion, according to Benzinga Pro. The company ...

Eli Lilly and Co (NYSE:LLY) stock is trading higher after the company released better-than-expected fourth-quarter earnings ...

Eli Lilly earnings topped Q4 views with 2025 guidance above consensus, even though Zepbound and Mounjaro slightly missed. Eli Lilly stock rose.

Eli Lilly (LLY) investors should expect fireworks this week as the pharma giant prepares to drop its bombshell Q4 2024 ...